Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Evaluating the effectiveness of addiction treatments: reasonable expectations, appropriate comparisons.

McLellan AT, Woody GE, Metzger D, McKay J, Durrell J, Alterman AI, O'Brien CP.

Milbank Q. 1996;74(1):51-85. Review.

PMID:
8596524
2.

Improving drug addiction treatment in China.

Tang YL, Hao W.

Addiction. 2007 Jul;102(7):1057-63. Review.

PMID:
17567394
3.

Cost-effectiveness of substance abuse services. Implications for public policy.

Shepard DS, Larson MJ, Hoffmann NG.

Psychiatr Clin North Am. 1999 Jun;22(2):385-400, x. Review.

PMID:
10385940
4.

Promotion of evaluation as a strategy towards an effective substance prevention.

Ostaszewski K.

Eur Addict Res. 1998 Sep;4(3):128-33. Review.

PMID:
9742274
5.

Reconsidering the evaluation of addiction treatment: from retrospective follow-up to concurrent recovery monitoring.

McLellan AT, McKay JR, Forman R, Cacciola J, Kemp J.

Addiction. 2005 Apr;100(4):447-58. Review.

PMID:
15784059
6.

A review of 25 long-term adolescent tobacco and other drug use prevention program evaluations.

Skara S, Sussman S.

Prev Med. 2003 Nov;37(5):451-74. Review.

PMID:
14572430
7.

Mortality and morbidity attributable to use of addictive substances in the United States.

McGinnis JM, Foege WH.

Proc Assoc Am Physicians. 1999 Mar-Apr;111(2):109-18. Review.

PMID:
10220805
8.
9.

Economic costs of substance abuse, 1995.

Rice DP.

Proc Assoc Am Physicians. 1999 Mar-Apr;111(2):119-25. Review.

PMID:
10220806
10.

Prevention research and its actual application to health services.

Holder HD.

J Behav Health Serv Res. 2001 May;28(2):118-29. Review.

PMID:
11338324
11.

Treatment outcomes for drug abuse clients.

Tims FM, Fletcher BW, Hubbard RL.

NIDA Res Monogr. 1991;106:93-113. Review. No abstract available.

PMID:
1922300
12.

Family therapy approach to addiction.

Crowley P.

Bull Narc. 1988;40(1):57-62. Review.

PMID:
3064845
13.

Social aesthetics and the management of addiction.

Musalek M.

Curr Opin Psychiatry. 2010 Nov;23(6):530-5. doi: 10.1097/YCO.0b013e32833d36a6. Review.

PMID:
20689439
14.
15.
16.

Factors associated with the outcome of drug addiction treatment.

Delic M, Pregelj P.

Psychiatr Danub. 2013 Sep;25 Suppl 2:S337-40. Review.

17.

Impediments to comprehensive treatment models for substance-dependent women: treatment and research questions.

Hagan TA, Finnegan LP, Nelson-Zlupko L.

J Psychoactive Drugs. 1994 Apr-Jun;26(2):163-71. Review.

PMID:
7931861
18.

Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation.

McLellan AT, Lewis DC, O'Brien CP, Kleber HD.

JAMA. 2000 Oct 4;284(13):1689-95. Review.

PMID:
11015800
19.

[Assessment of treatment efficacy for addictive diseases].

Zobin ML.

Zh Nevrol Psikhiatr Im S S Korsakova. 2007;Suppl 1:74-8. Review. Russian.

PMID:
18924469

Supplemental Content

Support Center